Available 1.7 mg/0.75 mL Available according to the FDA and were receiving no reports of supply issues
J Allergy Clin Immunol Pract 5(3):831833 Holtzer CD, Flaherty JF Jr, Coleman RL (1998) Cross-reactivity in HIV-infected patients switched from trimethoprim-sulfamethoxazole to dapsone
Record lot, solvent, concentration, preparation time, temperature and storage duration because these variables can affect oxidation and stability
[1] [2] Some individuals report a feeling of unsteadiness or difficulty concentrating, which can affect daily activities and quality of life
The Research Gap Phase I safety trials have been conducted but results were never published despite completed status
IBS, irritable bowel syndrome